ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,370,112 | +2.3% | 799,546 | +37.7% | 0.92% | +21.7% |
| Q1 2024 | $10,136,333 | +115.1% | 580,546 | +398.3% | 0.75% | +54.1% |
| Q1 2023 | $4,711,826 | -26.5% | 116,514 | -15.5% | 0.49% | -47.0% |
| Q4 2022 | $6,411,107 | +0.5% | 137,814 | +12.0% | 0.92% | +6.1% |
| Q3 2022 | $6,381,000 | +35.0% | 123,014 | +23.0% | 0.87% | +17.6% |
| Q2 2022 | $4,727,000 | -67.2% | 100,000 | -50.6% | 0.74% | -60.4% |
| Q1 2022 | $14,413,000 | -39.4% | 202,485 | -36.4% | 1.86% | -22.0% |
| Q4 2021 | $23,801,000 | +129.7% | 318,275 | +74.5% | 2.38% | +47.6% |
| Q3 2021 | $10,362,000 | +1870.0% | 182,400 | +1486.1% | 1.62% | +478.9% |
| Q3 2020 | $526,000 | -8.8% | 11,500 | 0.0% | 0.28% | -15.2% |
| Q2 2020 | $577,000 | +5.9% | 11,500 | +8.5% | 0.33% | -48.1% |
| Q1 2020 | $545,000 | – | 10,600 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |